Corporate Finance

With a $50M seed round, Radical Numerics aims to build general biological intelligence, walking a fine line between curing disease and creating bioweapons.

With projections of $22.7M from four new supplements, Cosmos Health is betting big on the US. But can its 'science-driven' platform deliver in a crowded market?

A Brooklyn startup is using software to slash production times for a critical industrial part from months to weeks, signaling a major shift for US manufacturing.

Facing a 'going concern' warning and collapsing revenue, Splash Beverage Group is ditching drinks for drugs. Its investment in Avicanna is a desperate, yet strategic, pivot.

A small Houston firm's modular waste-to-methanol plant in Porto is more than a green project; it's a strategic blueprint for European energy sovereignty.

Clip Money extends its debt runway, but a split among investors reveals a deeper story. Is this a savvy move to fuel expansion or a necessary patch on a leaky hull?

Rapid ticket sales for Country Stampede 2026 are just the beginning. Kustom Entertainment is leveraging market demand to fuel a major strategic expansion in Kansas.

In a year with the fewest home sales since 2007, one Nevada real estate team didn't just survive; it dominated. Here's how they did it.

As AI devalues technical skills, a new framework argues your lived experience is becoming priceless. Discover how to leverage your 'Masterwork Years' for lasting impact.

With over 4.6% of all ETH, Bitmine is not just mining crypto; it's engineering a new kind of financial institution. Is its high-stakes strategy genius or hubris?

With its Calcatreu mine now in production, Patagonia Gold hires a 40-year veteran to systematically unlock the value of its 375 Argentine properties.

After its landmark IPO, Action Energy Co. is moving to stabilize its stock. We explore how this technical move signals a new era for investors in Kuwait.

Formerly Hoth Therapeutics, Rocket One is betting its future on novel spintronic computing. A look at the tech, the risks, and the ambitious strategy.

A surge in Canadian professionals planning job changes in late 2026 reveals a market driven by new ambitions and complicated by the dual impact of AI.

A new partnership between AI consultancy Toboggan Labs and research giant Mila aims to solve a critical problem: turning cutting-edge AI into real-world medical tools.

Padel is exploding across North America, but its growth depends on quality infrastructure. A new partnership marries local manufacturing with global tech.

As BOXABL eyes a UK entry amid a housing crisis, is its modular tech a real solution or a strategic move to boost its upcoming public listing?

Trading Technologies partners with ICE to launch a new fixed income EMS, aiming to shatter market silos with a unified multi-asset trading experience.

Beyond a steady distribution, Chartwell's latest update signals a bold repositioning strategy. What does it mean for investors and the market?

Tiziana Life Sciences’ chairman just increased his massive stake. We analyze if this is a vote of confidence in its novel MS drug or a risky bet on a fragile biotech.